- Open Access
A marine sponge associated strain of Bacillus subtilis and other marine bacteria can produce anticholinesterase compounds
© Pandey et al.; licensee BioMed Central Ltd. 2014
Received: 10 January 2014
Accepted: 12 February 2014
Published: 15 February 2014
Acetylcholinesterase (AChE) inhibitors or anticholinesterases reduce the activity of enzyme acetylcholinesterase that degrades the neurotransmitter acetylcholine in the brain. The inhibitors have a significant pharmacological role in neurodegenerative diseases like Alzheimer’s and Parkinson’s etc. Although plants have been a significant source of these compounds, there are very few sporadic reports of microorganisms producing such inhibitors. Anticholinesterase activity in bacterial associates of marine soft corals and sponges were not previously reported.
We screened 887 marine bacteria for the presence of acetylcholinesterase inhibitors, in a microplate based assay, and found that 140 (15.8%) of them inhibit the electric eel enzyme, acetylcholinesterase. Majority of the active isolates were bacterial associates of soft corals followed by sediment isolates while most of the potent inhibitors belonged to the bacterial associates of marine sponges. Maximum inhibition (54%) was exhibited by a bacterial strain M18SP4P (ii), isolated from the marine sponge Fasciospongia cavernosa. Based on phenotypic characterization and 16S rDNA sequencing, the strain was identified as Bacillus subtilis - revealing yet another activity in a strain of the model organism that is considered to be a cell factory. TLC bioautography of the methanol extract of this culture, showed the presence of two major components having this activity, when compared to Galanthamine, the positive control.
From the results of our study, we conclude that acetylcholinesterase inhibitors are quite prevalent in marine bacteria, particularly the bacterial associates of marine invertebrates. Several potential AChE inhibitors in marine bacteria are waiting to be discovered to provide easily manipulable natural sources for the mass production of these therapeutic compounds.
Acetylcholinesterase inhibitors (AChEIs) work by increasing the concentration of acetylcholine (ACh) in the brain, due to reduction in the rate of its breakdown by acetylcholinesterase (AChE). These inhibitors, naturally found in venoms, have a range of applications from pharmaceuticals to insecticides and weapons like nerve gas . An important therapeutic use of AChE inhibitors is in the treatment of dementia associated with Alzheimer’s disease. There is no cure yet for this disease; four out of five FDA approved drugs are AChE inhibitors, which provide symptomatic relief, by improving signal transfer in the brain and slowing down the neurofibrillary degeneration . However, the importance of acetylcholinesterase inhibitors cannot be underestimated because recent research shows that these inhibitors protect brain cells against free radical injury and β-amyloid toxicity in Alzheimer’s disease (AD) . Despite the quest for new treatments to stop, slow or prevent AD, researchers around the world are looking for new sources of AChE inhibitors also, because of the concerns around the bioavailability and side-effects issues, associated with the existing, mostly synthetic, drugs for AD.
The natural sources are favoured for screening AChE inhibitors since they present enormous possibilities of discovering novel chemical structures with better properties. Majority of AChE inhibitors are derived from plants [1, 4], but they were also isolated from extracts of some algae, fungi, cyanobacteria, marine phytoplankton and marine sessile organisms like sponges and soft corals. For example, anticholinesterase compounds like the arisugacin, sporothrin and curvularin have been isolated from fungi [5–7]; sargaquinoic acid was found in marine alga Sargassum sagamianum and recently, biruloquinone isolated from a lichen forming fungi Cladonia macilenta, was identified as an inhibitor of acetylcholinesterase .
Very few AChE inhibitor compounds have been isolated from the bacterial sources. AChEI activity in bacteria was first reported in Streptomyces antibioticus, when two related furo-dioxa-phosphepin organophosphorus compounds, used in pesticides, were isolated from its cultures . Subsequently, another AChE inhibitor, cyclophostin was found in Strepomyces lavendulae. In the recent past, marinoquinoline A (a new alkaloid possessing pyrroloquinoline skeleton) was isolated from a marine gliding bacterium Rapidithrix thailandica (phylum Bacteroidetes). The AChE inhibitory activity of marinoquinoline A was discovered, after the compound was found to be structurally related to tacrine, which is an AChE inhibitor . Marinoquinoline A was again isolated from another novel marine Bacteroidetes member Ohtaekwangia kribbensis; hence this organism may, as well, inhibit AChE.
The latest discoveries about marinoquinoline A, coupled with, the reports claiming novel inhibitors from chemical investigations of marine sessile organisms [14–16], strongly indicate the potential of bacteria as a source of these important compounds from marine samples. Considering the enormous diversity of marine microorganisms, we set out to find the prevalence of acetylcholinesterase inhibitors in marine bacteria isolated from different samples of marine sponges, soft corals and sediments, using a high throughput microplate based assay. In this research report, we present an interesting finding that uncovers another activity - AChE inhibition - of a robust microorganism, amenable to manipulation and biotechnological scale-up for the production process.
AChE inhibition activity in marine isolates
No. of isolates screened
No. of active isolates
Percentage of active isolates (%)
No. of isolates showing >10% AChE inhibition activity
Identification of M18SP4Q (ii)
Biochemical characterization data of M18SP4Q (ii)
Singles & pairs
15 to 40°C
Growth at 6.5% NaCl
Growth under anaerobic condition
Voges Proskauer test
TLC bioautography of M18SP4Q (ii)
Many prominent researchers have reviewed the literature on marine natural products and unequivocally hailed the bioactive potential of marine microbes. Some of them proposed and demonstrated that marine invertebrate associated microbes are the primary producers of biologically active metabolites and play an important role in the host defense [20, 21]. Nonetheless, very few studies have identified the microbial producers of sponge-associated compounds; on the other hand, few microorganisms of the diverse microbial community associated with the sponges have a known function. Although bridging this gap is not so easy for a single research group, we initiated a basic search for a function, i.e., acetylcholinesterase inhibition, in the diverse microbial associates of sponges, sediment and soft corals. This research report is the first account of AChE inhibition activity in the microbial associates of the marine invertebrates and sediment.
Screening results analysis
Our findings showed a significant number, constituting 16%, of the isolates screened in this study with AChE inhibition activity. The major share of the positive cultures comes from soft corals followed by the sediment and sponge samples (Figure 1). Literature reviews of natural product AChE inhibitors shows that the majority of AChEIs are alkaloids followed by mono-, di-, tri- and sesqui-terpenes; while a few flavonoids, coumarins and other compounds are also on the list . Soft corals are known to produce different types of terpenes; as a recent example, Bonnard et al.  discovered novel bioactive natural terpenes upon chemical investigations of comorian soft corals. There are some studies showing coral-associated microorganisms as the biosynthetic source of terpene derivatives; like, the dinoflagellate Symbiodinium sp. was identified as a producer of pseudopterosins, the pharmacologically important diterpene glycosides, in a gorgonian soft coral . Although these findings are not connected, it is apparent that the AChE inhibiting terpenes have been found in different soft coral extracts, and coral microbial symbionts too have been shown to produce a class of terpenes. A very recent study, using the new technique of “genome mining” , also reveals tremendous biosynthetic potential of several bacterial species for terpene synthesis. Hence, it may be assumed that the terpenes isolated from different soft coral may have originated in the associated microbes.
Other chemical compounds from invertebrate extracts may show similar links if studied in depth because literature is replete with reports which show the involvement of different chemical classes of compounds in many of the biological activities. If such different classes of compounds can show the same activity, the chances of these compounds being found in the microbial world are not surprising. It has been observed in chemical investigations of natural extracts that the novel compounds are mostly variants or derivatives of existing major chemical classes of compounds. So, the general opinion of microbes being the primary producers of sponge or coral metabolites may gather more proofs with the concerted efforts of marine microbiologists and natural product chemists. This also explains why such large numbers of marine isolates exhibited AChEI activity.
AChEIs in sponge microbes
An examination of Table 1 shows that the maximum number of active isolates belong to the sponge Siphonodictyon coralliphagum, exhibiting consistently higher percentages of inhibition as compared to all other isolates. Earlier, a number of new meroterpenoid and spirosesquiterpene aldehyde compounds, like corallidictyals and liphagal; siphonodictyal sulfate and akadisulfates, have been isolated from the extracts of the sponge Siphonodictyon coralliphagum (= Aka coralliphaga); which showed protein kinase C inhibition, PI3K inhibitory activity and radical-scavenging activity respectively [25–27]. Some siphonodictyals and corallidictyals have also been reported to have antimicrobial activity [28, 29]. The other sponges from which compounds with antimicrobial activity have been isolated are Fasciospongia cavernosaand Acanthella cavernosa[31–33]. A careful study of the previous literature showed that several compounds with AChEI activity, isolated from the sponges, mostly derivatives of alkaloids and terpenes . However, anticholinesterase activity of the compounds of the above mentioned sponges or their microbial associates was not known so far, which may be due to limited research in this area. Recently, a web resource - DESMSCI – was developed for knowledge generation on marine sponge compounds interactions including a useful “hypothesis generation” feature . Using this web resource, the authors could generate and theoretically validate a hypothesis, by linking terms from different dictionaries. According to this hypothesis there is a possibility of finding a novel mode of action for a sponge compound variolin (an alkaloid) in AD. Thus, it is apparent that sponge compounds, like alkaloids, may not just inhibit AChE to provide symptomatic relief in AD, but may even have a disease modifying effect which needs to be studied in depth.
AChEI in Bacillus subtilis
The isolate M18SP4Q (ii), which showed the maximum percentage of AChE inhibition in the present screening, was taxonomically identified as Bacillus subtilis. This omnipresent saprophytic bacterium can survive in extreme conditions and is ecologically important due to its ability to produce a wide variety of enzymes; as a result, they play varied role from nutrient recycling to heavy metal accumulation or detoxification. Besides enzymes, they also produce antibiotics and their biosurfactant lipopeptides, called surfactins, have been reported to have mosquito larvicidal and pupicidal activity [35–37]. It is also commercially used in the production of amylase, protease, lipase, amino acids, inosine, ribosides, hyaluronic acid and polyhydroxybutarate. Bacillus subtilis is a favorable workhorse for the biotechnology industry because it is highly responsive to genetic manipulation. Recently, van Dijl and Hecker  suggested that Bacillus subtilis can be engineered into next-generation super-secreting cell factory using combined systems and synthetic biology approach. Thus, the detection of acetylcholinesterase inhibition in a Bacillus subtilis strain is certainly a significant finding.
Diversity of bacteria with AChEI activity
Microbes producing AChE inhibitors are few and far between in the past literature. In our taxonomic investigation of some marine bacteria, we found several different genera of bacteria produce AChE inhibitors, like, Psychrobacter, Microbacterium, Stenotrophomonas, Planococcus, Nocardia, Streptomyces sp., Leucobacter, Bacillus sp., Virgibacillus and Brevibacterium sp. (Additional file 2: Table S2), apart from the Bacillus subtilis strain. Involvement of diverse groups of microorganisms in AChE inhibitor production increases the chances of finding structurally unique metabolites. Recently, phylogenetically diverse urea utilizing microbes associated with the sponge Xestospongia testudinaria was reported, and our group has also reported a diverse marine microbial community producing beta-glucosidase inhibitors [39, 40]. The research on marine bacteria has not been extensive; therefore, the bioactive strains isolated from marine samples may present themselves as new to natural products research. Thus, the efforts to screen natural products from marine bacteria for industrially important activities are desirable conjointly with the molecular techniques in the metagenomic era.
Acetylcholinesterase inhibitors in bacteria have not received adequate attention of the researchers. Our assumption on the preponderance of AChEIs in marine bacteria proved to be correct. The AChEI activity has been detected in good numbers, in the microbial associates of soft corals, sponges and sediments. Bacillus subtilis - a well studied and exploited species - presented yet another activity, though it remains to be seen whether the compound responsible for this activity is new or known. These results imply that many anticholinesterase compounds are waiting to be discovered in marine bacteria of different lineages. Chemical investigation of hits from this study may be pursued in order to use these compounds. In future, the marine microbial secondary metabolites may be considered for further studies in the development of drugs for the treatment of AD because the present work shows a significant number of marine bacteria possess anticholinesterase activity.
Materials and methods
AChE Type VI-S, EC 126.96.36.199, from electric eel (Electrophorus electricus) and galanthamine hydrobromide from Lycoris sp. were purchased from Sigma (St. Louis, MO, USA). Acetylthiocholine iodide (ATCI), 5,5’-dithiobis-(2-nitrobenzoic acid) (DTNB), bovine serum albumin (BSA), dimethylsulfoxide (DMSO), Tris–HCl and microbiological media were procured from HiMedia Laboratories Pvt. Ltd., Mumbai, India. The chemicals used in the study were of the highest purity and used without further purification.
Buffers and reagents
A stock solution of 1.17 mg/ml acetylcholinesterase (425.94 U/mg) was prepared with 0.1% BSA in buffer A (50 mM Tris–HCl, pH-8) and stored in −20°C, and working solutions of 0.01 U/ml and 3 U/ml were prepared by dilution. Phosphate buffer (pH 7.5), 1.5 mM ATCI reconstituted in phosphate buffer and 3 mM DTNB in phosphate buffer. Galanthamine 5 mg/ml was dissolved in methanol and further diluted in phosphate buffer to make a working stock of 0.1 μM ml-1.
Bacterial strains and culture conditions
A large number of marine microorganisms were isolated from the samples of marine sponges, soft corals and sediment, collected from the Bay of Bengal on the east coast of India. The initial isolations were carried out on a variety of media prepared in seawater at temperatures ranging from 20-30°C. Many of these isolates were screened for the investigation of the presence of acetylcholinesterase inhibitors in the associates of marine sponges, soft corals and sediment samples. In this study, a total of 887 marine microorganisms isolated from samples of 8 sponges [total n = 500; Rhabdastrella globostella (n = 127), Acanthella cavernosa (n = 39), Dragmacidon agariciforme (n = 110), Leiodermatium pfeifferae (n = 72), Fasciospongia cavernosa (n = 08), Xestospongia testudinaria (n = 36), Siphonodictyon coralliphagum (n = 31) and Sarcotragus fasciculatus (n = 77)], 2 unidentified soft corals (n = 66) and 5 sediments (n = 321) were investigated. All these organisms grew on Nutrient Agar media (HiMedia, Mumbai) prepared in 50% aged natural seawater at 30°C within 48–72 hrs.
Extraction of metabolites
The microbial metabolites were extracted as described in Pandey et al. . Briefly, the cultures were grown in 50 ml of Nutrient Broth with 50% seawater, at 30°C/48 hrs and 200 rpm in a rotary shaker, followed by centrifugation at 9000 rpm/20 min to remove the cell mass. The supernatant was mixed with 10% Diaion HP-20 (Sigma) resin for 30 min on a magnetic stirrer. Then the Diaion resin along with supernatant was packed in a glass column, washed with 15 ml distilled water, and eluted with 20 ml methanol. The collected methanol was evaporated, and the extract was dissolved in DMSO.
AChE inhibition assay
where Asample was the absorbance of the sample microbial extract, and Acontrol was the absorbance of the blank reaction mixture without the inhibitor - negative control.
TLC bioautographic assay was carried out for the crude extract (IMM46), from the isolate M18SP4Q (ii) that showed the highest inhibition of AChE, as described by Rhee et al. , but with some modifications in the reagent concentrations. The substrate ATCI and chromogen DTNB was prepared as 2 mM solutions in 10 ml of buffer A. TLC assay was done on Silicagel 60 F 254 nm plates of 0.2 mm thickness with 1 μL each of M18SP4Q (ii) extract (100 mg/ml) and 1 μL of 0.1 μM ml-1 galanthamine spotted on the plate, developed in chloroform:methanol (8:2) in the mobile phase. After the TLC plate was developed, equal volume of 2 mM solutions of ATCI and DTNB was sprayed on the TLC plate until the plate was saturated. The plate was air dried for 5 min and then the enzyme - 10 ml of 3 U/ml AChE enzyme solution - was sprayed on the TLC plate. Yellow colour appeared within 5–10 min on the TLC plate except in places where the inhibitor was present.
The isolate, M18SP4Q (ii), was identified by partial 16S rRNA gene sequencing and phenotypic characterization . The colony and cell morphology, including spores, were characterized, and starch, nitrate, VP and NaCl tolerance tests were performed as described by Claus and Berkeley . The 16S rRNA gene based identification was done as described in Pandey et al. (36). Briefly, a 25 μl PCR reaction was set up with 10 pmol primers – 27 F and 1492R, 150 ng DNA, 5 mM dNTPs, 1× Taq polymerase buffer containing 15 mM MgCl2 and 0.5 μl of Taq DNA polymerase (5 U/μl, Fermentas) as per the programme: 94°C for 5 min, 30 cycles of 94°C for 1 min, 50°C for 1 min, 72°C for 2 min and 72°C for 10 min. The PCR product was separated on 1% agarose gel, and the DNA fragments were extracted. The purified 16S rDNA was sequenced in Beckman Coulter Ceq 8000 genetic analysis system. The sequence thus obtained was deposited in GenBank and aligned with the other sequences using BLAST program in NCBI (http://blast.ncbi.nlm.nih.gov). The EzTaxon server 2.1 (http://eztaxon-e.ezbiocloud.net/) was also used to obtain the closest matching type strain sequences from the database. The identity of the strain was established based on the phenotypic characters and sequence identity.
The 16S rDNA sequences of the closest relatives (type strains) of the strain M18SP4Q (ii) were retrieved from EzTaxon, and multiple sequence alignment was performed using Clustal_X program . The evolutionary relatedness of the strain was inferred using the Neighbor-Joining method, distance calculated using the p-distance method, followed by bootstrap test in 1000 replicates for each cluster and the phylogenetic tree was drawn in MEGA5.0 program available at http://www.megasoftware.net/.
The authors are thankful to Council of Scientific and Industrial Research for funding the work and Director CSIR-IMMT for the infrastructure support. We gratefully acknowledge Dr. Tapan Chakrabarti, former Head and founder of Microbial Type Culture Collection – an International Depository Authority, Chandigarh, India, for critically examining the manuscript.
- Houghton PJ, Rena Y, Howesb MJ: Acetylcholinesterase inhibitors from plants and fungi. Nat Prod Rep. 2006, 23: 181-199. 10.1039/b508966m.View ArticleGoogle Scholar
- Alzheimer's Association at http://www.alz.org/research/science/alzheimers_disease_treatments.asp
- Tabet N: Acetylcholinesterase inhibitors for Alzheimer’s disease: anti-inflammatories in acetylcholine clothing!. Age Ageing. 2006, 35: 336-338. 10.1093/ageing/afl027.View ArticleGoogle Scholar
- Williams P, Sorribasab A, Howesc MJR: Natural products as a source of Alzheimer’s drug leads. Nat Prod Rep. 2011, 28: 48-77. 10.1039/c0np00027b.View ArticleGoogle Scholar
- Otoguro K, Kuno F, Ōmura S: Arisugacins, selective acetylcholinesterase inhibitors of microbial origin. Pharmacol & Ther. 1997, 76 (1–3): 45-54.View ArticleGoogle Scholar
- Wen L, Cai X, Xu F, She Z, Chan WL, Vrijmoed LL, Jones EB, Lin Y: Three metabolites from the mangrove endophytic fungus Sporothrix sp. (#4335) from the South China Sea. J Org Chem. 2009, 74 (3): 1093-1098. 10.1021/jo802096q.View ArticleGoogle Scholar
- Kumar CG, Mongolla P, Sujitha P, Joseph J, Babu KS, Suresh G, Ramakrishna KV, Purushotham U, Sastry GN, Kamal A: Metabolite profiling and biological activities of bioactive compounds produced by Chrysosporium lobatum strain BK-3 isolated from Kaziranga National Park, Assam India. Springerplus. 2013, 2 (1): 122-doi:10.1186/2193-1801-2-122View ArticleGoogle Scholar
- Choi BW, Ryu G, Park SH, Kim ES, Shin J, Roh SS, Shin HC, Lee BH: Anticholinesterase activity of plastoquinones from Sargassum sagamianum: lead compounds for Alzheimer’s disease therapy. Phytother Res. 2007, 21: 423-426. 10.1002/ptr.2090.View ArticleGoogle Scholar
- Luo H, Li C, Kim JC, Liu Y, Jung JS, Koh YJ, Hur JS: Biruloquinone, an acetylcholinesterase inhibitor produced by lichen-forming fungus Cladonia macilenta. J Microbiol Biotechnol. 2013, 23 (2): 161-166. 10.4014/jmb.1207.07016.View ArticleGoogle Scholar
- Neumann R, Peter HH: Insecticidal organophosphates: nature made them first. Experientia. 1987, 43: 1235-1237. 10.1007/BF01945541. 10.1007/BF01945541.View ArticleGoogle Scholar
- Kurokawa T, Suzuki K, Hayaoka T, Nakagawa T, Izawa T, Kobayashi M, Harada N: Cyclophostin, acetylcholinesterase inhibitor from Streptomyces Iavendulae. J Antibiot. 1993, 46: 1315-1318. 10.7164/antibiotics.46.1315.View ArticleGoogle Scholar
- Sangnoi Y, Sakulkeo O, Yuenyongsawad S, Kanjana-opas A, Ingkaninan K, Plubrukarn A, Suwanborirux K: Acetylcholinesterase-inhibiting activity of pyrrole derivatives from a novel marine gliding bacterium, Rapidithrix thailandica. Mar Drugs. 2008, 6 (4): 578-586. 10.3390/md6040578.View ArticleGoogle Scholar
- Okanya PW, Mohr KI, Gerth K, Jansen R, Müller R: Marinoquinolines A-F, pyrroloquinolines from Ohtaekwangia kribbensis (Bacteroidetes). J Nat Prod. 2011, 74 (4): 603-608. 10.1021/np100625a.View ArticleGoogle Scholar
- Bonnard I, Jhaumeer-Laulloo SB, Bontemps N, Banaigs B, Aknin M: New lobane and cembrane diterpenes from two Comorian soft corals. Mar Drugs. 2010, 8: 359-372. 10.3390/md8020359.View ArticleGoogle Scholar
- Sepcić K, Guella G, Mancini I, Pietra F, Serra MD, Menestrina G, Tubbs K, Macek P, Turk T: Characterization of anticholinesterase-active 3-alkylpyridinium polymers from the marine sponge Reniera sarai in aqueous solutions. J Nat Prod. 1997, 60 (10): 991-996. 10.1021/np970292q.View ArticleGoogle Scholar
- Langjae R, Bussarawit S, Yuenyongsawad S, Ingkaninan K, Plubrukarn A: Acetylcholinesterase-inhibiting steroidal alkaloid from the sponge Corticium sp. Steroids. 2007, 72: 682-685. 10.1016/j.steroids.2007.05.005.View ArticleGoogle Scholar
- Saitou N, Nei M: The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol. 1987, 4: 406-425.Google Scholar
- Felsenstein J: Confidence limits on phylogenies: an approach using the bootstrap. Evolution. 1985, 39: 783-791. 10.2307/2408678. 10.2307/2408678.View ArticleGoogle Scholar
- Nei M, Kumar S: Molecular evolution and phylogenetics. 2000, Oxford University Press: New YorkGoogle Scholar
- Newmann DJ, Hill RT: New drugs from marine microbes: the tide is turning. J Ind Microbiol Biotechnol. 2006, 33: 539-544. 10.1007/s10295-006-0115-2.View ArticleGoogle Scholar
- Webster NS, Taylor MW: Marine sponges and their microbial symbionts: love and other relationships. Environ Microbiol. 2012, 14 (2): 335-346. 10.1111/j.1462-2920.2011.02460.x.View ArticleGoogle Scholar
- Filho JMB, Medeiros KCP, Diniz MF, Batista LM, Filho PFA, Silva S, Cunha EVL, Almeida JRGS, Quintans LJ: Natural products inhibitors of the enzyme acetylcholinesterase. Braz J Pharmacog. 2006, 16 (2): 258-285.Google Scholar
- Mydlarz LD, Jacobs R, Boehnlein J, Kerr RG: Pseudopterosin biosynthesis in Symbiodinium sp., the dinoflagellate symbiont of Pseudopterogorgia elisabethae. Chem Biol. 2003, 10 (11): 1051-1056. 10.1016/j.chembiol.2003.10.012.View ArticleGoogle Scholar
- Cane DE, Ikeda H: Exploration and mining of the bacterial terpenome. Acc Chem Res. 2012, 45 (3): 463-472. 10.1021/ar200198d.View ArticleGoogle Scholar
- Chan JA, Freyer AJ, Carté BK, Hemling ME, Hofmann GA, Mattern MR, Mentzer MA, Westley JW: Protein kinase C inhibitors: novel spirosesquiterpene aldehydes from a marine sponge Siphonodictyon coralliphagum. J Nat Prod. 1994, 57 (11): 1543-1548. 10.1021/np50113a011.View ArticleGoogle Scholar
- Marion F, Williams DE, Patrick BO, Hollander I, Mallon R, Kim SC, Roll DM, Feldberg L, Van Soest R, Andersen RJ: Liphagal, a Selective inhibitor of PI3 kinase alpha isolated from the sponge Aka coralliphaga: structure elucidation and biomimetic synthesis. Org Lett. 2006, 8 (2): 321-324. 10.1021/ol052744t.View ArticleGoogle Scholar
- Shubina LK, Kalinovsky AI, Makarieva TN, Fedorov SN, Dyshlovoy SA, Dmitrenok PS, Kapustina II, Mollo E, Utkina NK, Krasokhin VB, Denisenko VA, Stonik VA: New meroterpenoids from the marine sponge Aka coralliphaga. Nat Prod Commun. 2012, 7 (4): 487-490.Google Scholar
- Sullivan B, Djura P, Mcintyre DE, Faulkner DJ: Antimicrobial constituents of the sponge Siphonodictyon coralliphagum. Tetrahedron. 1981, 37 (5): 979-982. 10.1016/S0040-4020(01)97672-0.View ArticleGoogle Scholar
- Grube A, Assmann M, Lichte E, Sasse F, Pawlik JR, Köck M: Bioactive metabolites from the Caribbean sponge Aka coralliphagum. J Nat Prod. 2007, 70: 504-509. 10.1021/np0603018.View ArticleGoogle Scholar
- Rosa S, Crispino A, Giulio A, Iodice C, Pronzato R, Zabodnik N: Cacospongionolide B, a new sesterterpene from the Sponge Fasciospongia cavernosa. J Nat Prod. 1995, 58 (11): 1776-1780. 10.1021/np50125a024.View ArticleGoogle Scholar
- Trimurtulu G, Faulkner JD: Six new diterpene isonitriles from the sponge Acanthella cavernosa. J Nat Prod. 1994, 57 (4): 501-506. 10.1021/np50106a009.View ArticleGoogle Scholar
- Okino T, Yoshimura E, Hirota H, Fusetani N: Antifouling kalihinenes from the marine sponge Acanthella cavernosa. Tetrahedron Lett. 1995, 36 (47): 8637-8640. 10.1016/0040-4039(95)01861-B.View ArticleGoogle Scholar
- Jumaryatno P, Trevor KR, Blanchfield JT, Garsona MJ: Isocyanates in marine sponges: axisocyanate-3, a new sesquiterpene from Acanthella cavernosa. ARKIVOC. 2007, 157-166. viiGoogle Scholar
- Sagar S, Kaur M, Radovanovic A, Bajic VB: Dragon exploration system on marine sponge compounds interactions. J Cheminform. 2013, 5: 11-doi:10.1186/1758-2946-5-11View ArticleGoogle Scholar
- Geetha I, Manonmani AM, Paily K: Identification and characterization of a mosquito pupicidal metabolite of a Bacillus subtilis subsp. subtilis strain. Appl Microbiol Biotechnol. 2010, 86 (6): 1737-1744. 10.1007/s00253-010-2449-y.View ArticleGoogle Scholar
- Zimmerman S, Schwartz CD, Monaghan RL, Pleak BA, Weissberger B, Gilfillan EC, Mochales S, Hernandez S, Currie SA, Tejera E, Stapley EO: Difficidin and oxydifficidin: Novel broad spectrum antibacterial antibiotics produced by Bacillus subtilis. J Antibiotics. 1987, 40 (12): 1677-1681. 10.7164/antibiotics.40.1677. 10.7164/antibiotics.40.1677.View ArticleGoogle Scholar
- Loeffler W, Tschen JSM, Vanittanakom N, Kugler M, Knorpp E, Hsieh TF, Wu TG: Antifungal effects of bacilysin and fengymycin from Bacillus subtilis F-29-3: A comparison with activities of other Bacillus antibiotics. J Phytopathol. 1986, 115 (3): 204-213. 10.1111/j.1439-0434.1986.tb00878.x. 10.1111/j.1439-0434.1986.tb00878.x.View ArticleGoogle Scholar
- van Dijl JM, Hecker M: Bacillus subtilis: from soil bacterium to super-secreting cell factory. Microb Cell Fact. 2013, 12: 3-doi:10.1186/1475-2859-12-3View ArticleGoogle Scholar
- Su J, Jin L, Jiang Q, Sun W, Zhang F, Li Z: Phylogenetically diverse ureC genes and their expression suggest the urea utilization by bacterial symbionts in marine sponge Xestospongia testudinaria. PLoS ONE. 2013, 8 (5): e64848-doi:10.1371/journal.pone.0064848View ArticleGoogle Scholar
- Pandey S, Sree A, Dash SS, Sethi DP, Chowdhury L: Diversity of marine bacteria producing beta-glucosidase inhibitors. Microb Cell Fact. 2013, 12: 35-doi: 10.1186/1475-2859-12-35View ArticleGoogle Scholar
- Featherstone RM, Andres V, Ellman GL, Courtney KD: A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 1961, 7: 88-95. 10.1016/0006-2952(61)90145-9.View ArticleGoogle Scholar
- Rhee IK, van de Meent M, Ingkaninan K, Verpoorte R: Screening for acetylcholinesterase inhibitors from Amaryllidaceae using silica gel thin-layer chromatography in combination with bioactivity staining. J Chromatogr A. 2001, 915 (1–2): 217-223.View ArticleGoogle Scholar
- Reva ON, Sorokulova IB, Smirnov VV: Simplified technique for identification of the aerobic spore-forming bacteria by phenotype. IJ SEM. 2001, 51: 1361-1371.Google Scholar
- Claus D, Berkeley RCW: Genus bacillus Cohn 1872. Bergey’s Manual of Systematic Bacteriology, Volume 2. Edited by: Holt JG, Sneath PHA, Mair NS, Sharpe ME. 1986, 1105-1139. Baltimore, MD: Williams and WilkinsGoogle Scholar
- Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG: The CLUSTAL_X Windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 1997, 25: 4876-4882. 10.1093/nar/25.24.4876.View ArticleGoogle Scholar
- Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S: MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol. 2011, 28: 2731-2739. 10.1093/molbev/msr121.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.